NealFlomenbergMDProfessor & Chair

Clinical Trials

• Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation Start of enrollment: 1998 Jul 22

  Completed

  Phase 2

• Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 1998 Jan 01

  Completed

  Phase 1

• Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Start of enrollment: 2001 Nov 19

  Completed

  Phase 2

• Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias Start of enrollment: 2006 Jan 01

  Completed

  Phase 1, Phase 2

• A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation Start of enrollment: 2000 Sep 01

  Terminated

  Phase 2

• A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative Start of enrollment: 2006 Jan 01

  Completed

  Phase 1, Phase 2

• Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma Start of enrollment: 2009 Feb 05

  Completed

  Phase 2

• A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies Start of enrollment: 2008 Apr 10

  Completed

  Phase 2

• Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies Start of enrollment: 2010 May 01

  Completed

  Phase 2

• A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors Start of enrollment: 2011 Feb 10

  Completed

  Phase 2

• Treatment of Sickle Cell Anemia With Stem Cell Transplant Start of enrollment: 2009 Sep 01

  Terminated

  Not Applicable

• Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor Start of enrollment: 2010 Jul 01

  Completed

  Phase 2

• Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps Start of enrollment: 2011 Apr 01

  Terminated

  Phase 1, Phase 2

• Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma Start of enrollment: 2011 May 25

  Terminated

  Phase 1

• A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies Start of enrollment: 2011 Aug 04

  Completed

  Phase 2

• Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide Start of enrollment: 2011 Nov 09

  Completed

  Phase 1, Phase 2

• A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives Start of enrollment: 2012 Mar 01

  Terminated

  Phase 2

• Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant Start of enrollment: 2012 Aug 01

  Withdrawn

  Not Applicable

• Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies Start of enrollment: 2012 Dec 24

  Completed

  Phase 2

• Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2013 Mar 15

  Completed

  Early Phase 1

• Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy Start of enrollment: 2013 Jul 08

  Active, not recruiting

  Phase 2

• Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies Start of enrollment: 2013 May 17

  Terminated

  Phase 2

• Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor Start of enrollment: 2013 Nov 04

  Completed

  Phase 2

• Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2014 Aug 25

  Completed

  Phase 2

• Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma Start of enrollment: 2017 Oct 12

  Completed

  Phase 2

• 2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies Start of enrollment: 2018 Sep 19

  Active, not recruiting

  Phase 2

• Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung Cancer Start of enrollment: 2019 Feb 08

  Completed

  Not Applicable

• A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity Start of enrollment: 2017 Jan 31

  Recruiting

  Phase 2

  Roles: Contact

• Join now to see all